🔎 Trials Near Me

홈 › 신장암 (신세포암) › 텍사스

텍사스의 신장암 (신세포암) 임상 시험

신장암 (신세포암) 관련 연구 56개가 텍사스 내 여러 지역에서 참여자를 모집하고 있습니다.

텍사스의 도시

공식 연구 텍스트(영어)

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

  • Research Site, San Antonio
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT05536141

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

  • NEO-811 Dallas Site, Dallas
  • NEO-811 Houston Site, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT07300241

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

  • NEXT Austin, Austin
  • START Center for Clinical Research, Fort Worth
  • University of Texas MD Anderson Cancer Center, Houston
  • 외 1개
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06270706

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

  • Texas Oncology, Dallas
  • University of Texas Southwestern Medical Center, Dallas
  • University Medical Center & Texas Tech Health Science Center, Lubbock
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06234605

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • The Don and Sybil Harrington Cancer Center, Amarillo
  • UT MD Anderson Cancer Center, Houston
  • Audie L Murphy VA Hospital, San Antonio
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT05334069

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

  • Exelixis Clinical Site #46, Austin
  • Exelixis Clinical Site #89, Dallas
  • Exelixis Clinical Site #73, Irving
  • 외 2개
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT05176483

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

  • University of Texas - MD Anderson Cancer Center, Houston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT05287945

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • UT Southwestern Simmons Cancer Center - RedBird, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
  • UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
  • 외 1개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT03866382

Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

  • UT MD Anderson Cancer Center, Houston
피험자 모집 중2상
12세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT04981509

REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma

  • The University of Texas MD Anderson Cancer Center, Houston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07594106

DESTINY-PANTUMOUR04

  • Research Site, Dallas
피험자 모집 중관찰 연구
18세 ~ 130세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07124000

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

  • Baylor, Scott and White Research Institute, Dallas
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06047379

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

  • Texas Oncology (Balcones) - SCRI, Austin
  • MD Anderson Cancer Center, Houston
  • START South Texas Accelerated Research Therapeutics, San Antonio
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT05267626

A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases

  • M D Anderson Cancer Center, Houston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT05048212

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

  • Parkland Memorial Hospital, Dallas
  • UT Southwestern Simmons Cancer Center - RedBird, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
  • 외 3개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT05327686

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

  • Texas Oncology - Central South, Austin
  • Texas Oncology - Central South, Austin
  • Texas Oncology - Central South, Austin
  • 외 26개
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07227415

Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus

  • University of Texas Southwestern Medical Center, Dallas
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT05319015

TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma

  • The University of Texas MD Anderson Cancer Center, Houston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT04969315

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

  • Md Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT07195916

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • UT Southwestern Medical Center, Dallas
  • DHR Health Advance Care Center, Edinburg
  • The Center for Cancer and Blood Disorders, Forth Worth
  • 외 1개
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT05059444

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

  • Mary Crowley Cancer Research, Dallas
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT06750185

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

  • The Don and Sybil Harrington Cancer Center, Amarillo
  • Houston Methodist San Jacinto Hospital, Baytown
  • Houston Methodist Cypress Hospital, Cypress
  • 외 13개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT06661720

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

  • START San Antonio, San Antonio
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 27. 업데이트됨 · NCT06582017

Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma

  • MD Anderson Cancer Center, Houston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT06940518

Phase II Trial of Single Agent Belzutifan or Pembrolizumab Versus Combination as Neoadjuvant Therapy in Clear Cell Renal Cell Carcinoma (BLAZE)

  • The University of Texas M. D. Anderson Cancer Center, Houston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT07187778

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

  • Research Site, Houston
  • Research Site, San Antonio
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT07115043

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

  • University of Texas, Southwestern Medical Center, Dallas
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT05361720

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

  • NEXT Oncology, Austin, Austin
  • NEXT Oncology, San Antonio, San Antonio
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT06966024

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

  • Houston Methodist Hospital, Houston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT04895709

A Study of MGC026 in Participants With Advanced Solid Tumors

  • The University of Texas MD Anderson Cancer Center, Houston
  • University of Texas Health Science Center at Houston, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT06242470

A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

  • START San Antonio, San Antonio
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT07195682

Modulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept Study

  • The University of Texas M. D. Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT07187869

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

  • Clinical Trial Site, San Antonio
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 6. 업데이트됨 · NCT07749586

IDOV-Immune for Advanced Solid Tumors

  • MD Anderson Cancer Center, Houston
  • South Texas Accelerated Research Therapeutics, San Antonio
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT06910657

PET/MR for Characterization of Renal Masses (RMs)

  • University of Texas Southwestern Medical Center, Dallas
  • The University of Texas MD Anderson Cancer Center, Houston
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 8. 4. 업데이트됨 · NCT06076538

Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC

  • MD Anderson Cancer Center, Houston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 7. 30. 업데이트됨 · NCT05663710

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  • The University of Texas Health Science Center at Tyler, Tyler
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 7. 29. 업데이트됨 · NCT04198766

Phase 1 Study Of LNK001 In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma

  • UT MD Anderson, Houston
피험자 모집 중1상
18세 ~ 70세 · 모든 성별 · 2026. 7. 29. 업데이트됨 · NCT07564232

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

  • M D Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 16. 업데이트됨 · NCT05092373

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

  • MD Anderson Cancer Center, Houston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 7. 9. 업데이트됨 · NCT03972657

ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.